Literature DB >> 21556029

Rheumatoid arthritis: 2011 remission criteria are a new benchmark for RA therapy.

Vivian P Bykerk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21556029     DOI： 10.1038/nrrheum.2011.63

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

1.  Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states.

Authors:  Daniel Aletaha; Michael M Ward; Klaus P Machold; Valerie P K Nell; Tanja Stamm; Josef S Smolen
Journal:  Arthritis Rheum       Date:  2005-09

2.  Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?

Authors:  H Mäkinen; H Kautiainen; P Hannonen; T Sokka
Journal:  Ann Rheum Dis       Date:  2005-06-07       Impact factor: 19.103

Review 3.  DAS remission cut points.

Authors:  J Fransen; P L C M van Riel
Journal:  Clin Exp Rheumatol       Date:  2006 Nov-Dec       Impact factor: 4.473

4.  Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score.

Authors:  M L Prevoo; A M van Gestel; M A van T Hof; M H van Rijswijk; L B van de Putte; P L van Riel
Journal:  Br J Rheumatol       Date:  1996-11

5.  Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.

Authors:  S M van der Kooij; Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; M Güler-Yüksel; A H Zwinderman; P J S M Kerstens; P A H M van der Lubbe; W M de Beus; B A M Grillet; H K Ronday; T W J Huizinga; F C Breedveld; B A C Dijkmans; C F Allaart
Journal:  Ann Rheum Dis       Date:  2008-07-28       Impact factor: 19.103

6.  Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.

Authors:  Diane van der Woude; Adam Young; Keeranur Jayakumar; Bart J Mertens; René E M Toes; Désirée van der Heijde; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  Arthritis Rheum       Date:  2009-08

7.  Preliminary criteria for clinical remission in rheumatoid arthritis.

Authors:  R S Pinals; A T Masi; R A Larsen
Journal:  Arthritis Rheum       Date:  1981-10

8.  American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Authors:  David T Felson; Josef S Smolen; George Wells; Bin Zhang; Lilian H D van Tuyl; Julia Funovits; Daniel Aletaha; Cornelia F Allaart; Joan Bathon; Stefano Bombardieri; Peter Brooks; Andrew Brown; Marco Matucci-Cerinic; Hyon Choi; Bernard Combe; Maarten de Wit; Maxime Dougados; Paul Emery; Daniel Furst; Juan Gomez-Reino; Gillian Hawker; Edward Keystone; Dinesh Khanna; John Kirwan; Tore K Kvien; Robert Landewé; Joachim Listing; Kaleb Michaud; Emilio Martin-Mola; Pamela Montie; Theodore Pincus; Pamela Richards; Jeffrey N Siegel; Lee S Simon; Tuulikki Sokka; Vibeke Strand; Peter Tugwell; Alan Tyndall; Desirée van der Heijde; Suzan Verstappen; Barbara White; Frederick Wolfe; Angela Zink; Maarten Boers
Journal:  Arthritis Rheum       Date:  2011-03

9.  Treating rheumatoid arthritis to target: recommendations of an international task force.

Authors:  Josef S Smolen; Daniel Aletaha; Johannes W J Bijlsma; Ferdinand C Breedveld; Dimitrios Boumpas; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Maarten de Wit; Maxime Dougados; Paul Emery; Alan Gibofsky; Juan Jesus Gomez-Reino; Boulos Haraoui; Joachim Kalden; Edward C Keystone; Tore K Kvien; Iain McInnes; Emilio Martin-Mola; Carlomaurizio Montecucco; Monika Schoels; Désirée van der Heijde; Desirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-03-09       Impact factor: 19.103
  9 in total
  2 in total

1.  Sustained rheumatoid arthritis remission is uncommon in clinical practice.

Authors:  Femke H M Prince; Vivian P Bykerk; Nancy A Shadick; Bing Lu; Jing Cui; Michelle Frits; Christine K Iannaccone; Michael E Weinblatt; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2012-03-19       Impact factor: 5.156

2.  A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?

Authors:  Adrian M Shields; Gabriel S Panayi; Valerie M Corrigall
Journal:  Front Immunol       Date:  2012-02-17       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.